Holen Sie sich die Stockscreener-App
1.99
3.40%
-0.07
Handel nachbörslich:
2.03
0.04
+2.01%
Schlusskurs vom Vortag:
$2.06
Offen:
$2.09
24-Stunden-Volumen:
1.19M
Relative Volume:
1.70
Marktkapitalisierung:
$140.75M
Einnahmen:
$299.48M
Nettoeinkommen (Verlust:
$-86.45M
KGV:
-1.3267
EPS:
-1.5
Netto-Cashflow:
$-17.32M
1W Leistung:
-8.29%
1M Leistung:
-19.43%
6M Leistung:
-26.30%
1J Leistung:
-63.82%
1-Tages-Spanne:
$1.97
$2.09
1-Wochen-Bereich:
$1.97
$2.20
52-Wochen-Spanne:
$1.97
$5.6825
Health Catalyst Inc Stock (HCAT) Company Profile
Firmenname
Health Catalyst Inc
Sektor
Branche
Telefon
801-708-6800
Adresse
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT vs VEEV, TEM, BTSG, HQY, DOCS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
1.99 | 145.71M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
177.04 | 30.74B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
53.61 | 9.94B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
40.06 | 7.10B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
76.92 | 6.69B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
25.96 | 5.03B | 550.17M | 201.35M | 232.07M | 1.00 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-27 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-08-08 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2024-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-13 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-05-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-04-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-08-05 | Herabstufung | Stifel | Buy → Hold |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-03-17 | Hochstufung | Jefferies | Hold → Buy |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-10-14 | Eingeleitet | BTIG Research | Buy |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-06-18 | Eingeleitet | Stifel | Buy |
| 2020-06-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-05-15 | Eingeleitet | Guggenheim | Buy |
| 2020-04-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-20 | Eingeleitet | Raymond James | Strong Buy |
| 2019-10-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-08-19 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-19 | Eingeleitet | Goldman | Buy |
| 2019-08-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-08-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-19 | Eingeleitet | SunTrust | Buy |
| 2019-08-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Health Catalyst Inc Aktie (HCAT) Neueste Nachrichten
Will Health Catalyst Inc. stock maintain growth storyJuly 2025 Intraday Action & Stepwise Swing Trade Plans - mfd.ru
Health Catalyst leverages AI to enhance clinical outcomes - Traders Union
What drives Health Catalyst Incs stock priceTrade Performance Summary & Weekly Stock Breakout Alerts - baoquankhu1.vn
3 of Wall Street's Favorite Stocks We Approach with Caution - Finviz
Marquis Who's Who Honors Kristin Acree for Expertise in Public Health - lelezard.com
Why Health Catalyst (HCAT) Stock Is Trading Lower Today - Finviz
How Health Catalyst Turns Analytics Into Action Clinicians Actually Use - Healthcare IT Today
Bear Alert: What is the cash position of GOGOQuarterly Portfolio Review & Risk Managed Trade Strategies - baoquankhu1.vn
Health Catalyst, Inc (HCAT) Stock Analysis: Exploring a Compelling 76.94% Upside Potential - DirectorsTalk Interviews
Here's Why Health Catalyst (HCAT) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance
Analyst Calls: What is the dividend yield of Snowflake IncJuly 2025 Momentum & Long-Term Growth Portfolio Plans - baoquankhu1.vn
How The New Price Target Is Reframing Health Catalyst’s Story And Fair Value - Yahoo Finance
Support Test: Should I set a stop loss on Health Catalyst IncJuly 2025 Market Mood & Daily Growth Stock Tips - baoquankhu1.vn
Navigating 2026: How health systems can thrive amid AI, labor and consumer pressures - Modern Healthcare
Health Catalyst, Inc. (NASDAQ:HCAT) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Health Catalyst Announces Chief Commercial Officer Transition Plan - TipRanks
Health Catalyst, Inc. Announces Executive Changes - marketscreener.com
Health Catalyst, MongoDB, Asana, Domo, and RingCentral Stocks Trade Up, What You Need To Know - The Globe and Mail
Health Catalyst, Inc (HCAT) Stock Analysis: Evaluating the 68% Potential Upside for Investors - DirectorsTalk Interviews
Why Clinical Data Analytics Is Becoming One of Healthcare’s Fastest-Growing Markets? - GlobeNewswire Inc.
Q3 Earnings Highs And Lows: Health Catalyst (NASDAQ:HCAT) Vs The Rest Of The Data Analytics Stocks - Barchart.com
Nasdaq Moves: What are Health Catalyst Incs recent SEC filings showingMarket Movers & Daily Chart Pattern Signals - baoquankhu1.vn
Health Catalyst, Veeva Systems, 8x8, Amplitude, and DocuSign Stocks Trade Down, What You Need To Know - The Globe and Mail
Market Outlook: Can Health Catalyst Inc stock weather global recessionStop Loss & Risk Managed Investment Strategies - Bộ Nội Vụ
Health Catalyst stock reiterated as Buy at Stifel despite 2026 revenue guide - Investing.com Australia
Health Catalyst stock reiterated as Buy at Stifel despite 2026 revenue guide By Investing.com - Investing.com South Africa
HCAT Projects Strong Client Growth and EBITDA Goals for FY25 - GuruFocus
(HCAT) Health Catalyst Expects 2025 Revenue to Slightly Exceed Guidance of About $310 Million - marketscreener.com
Health Catalyst drives AI in healthcare to cut costs - Traders Union
Surprises Report: Is Health Catalyst Inc stock a top pick in earnings seasonJuly 2025 Outlook & Verified Swing Trading Watchlists - moha.gov.vn
Health Catalyst examines AI's tangible impact on healthcare - Traders Union
4 Analysts Have This To Say About Health Catalyst - Benzinga
HCAT: Citigroup Adjusts Price Target, Maintains Neutral Rating | - GuruFocus
Is Health Catalyst Inc. stock positioned well for digital economyWalking Comfort Picks & what to check before ordering - Улправда
Is Health Catalyst Inc. stock a top pick in earnings seasonJuly 2025 PreEarnings & Low Risk High Win Rate Picks - Улправда
How Health Catalyst Inc. stock compares to growth peers2025 Fundamental Recap & AI Powered Market Entry Strategies - Улправда
Can Health Catalyst Inc. stock rebound after recent weaknessMarket Rally & AI Driven Stock Movement Reports - Улправда
Is Health Catalyst Inc. stock a dividend growth opportunityJuly 2025 Action & Free Low Drawdown Momentum Trade Ideas - Улправда
Is Health Catalyst Inc. stock oversold or undervaluedMarket Risk Summary & Technical Pattern Alert System - Улправда
EPS Watch: Is Health Catalyst Inc stock positioned well for digital economy2025 Market Sentiment & Free Expert Approved Momentum Trade Ideas - Bộ Nội Vụ
3 Russell 2000 Stocks Walking a Fine Line - Finviz
3 Value Stocks We Find Risky - Finviz
Finanzdaten der Health Catalyst Inc-Aktie (HCAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.28%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):